Why Farbe Firma is the Top Manufacturer of Fat Emulsion Injection
- Maulik Sudani
- 23 hours ago
- 10 min read
Last Updated: July 1, 2026
TL;DR: Fat Emulsion Injection - a sterile oil-in-water emulsion of a purified vegetable and/or fish oil phase stabilised with egg-yolk phospholipid and made isotonic with glycerol, supplied commonly as a 10%, 20% or 30% w/v intravenous lipid emulsion in a glass bottle or non-PVC bag - is the concentrated source of calories and essential fatty acids that clinicians infuse as part of parenteral nutrition when a patient cannot be fed adequately by mouth or by the enteral route. Because an intravenous lipid emulsion is a delicate two-phase system whose safety depends on an extremely fine, uniform droplet population, each container must deliver a sterile, stable, correctly sized emulsion at the labelled strength, with the mean droplet size and the population of large-diameter globules (PFAT5) under USP <729>, emulsion physical stability, the egg-phospholipid emulsifier, oxidation and peroxide control, pH and osmolality, low particulate and endotoxin, a validated homogenisation and terminal sterilisation route and verified container-closure integrity all mattering to safety and shelf life. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Fat Emulsion Injection at our Gujarat, India facility and supplies it to hospital-pharmacy, critical-care, surgical, oncology and parenteral-nutrition services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Intravenous lipid emulsion for parenteral nutrition - a sterile oil-in-water emulsion of purified vegetable and/or fish oils stabilised with egg-yolk phospholipid, Fat Emulsion Injection (10%, 20% or 30% w/v, slow intravenous infusion) supplies concentrated calories and essential fatty acids and demands an extremely fine, uniform, correctly sized droplet population in every container.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated two-phase compounding and high-pressure homogenisation lines with nitrogen protection, control of the mean droplet size and the large-globule (PFAT5) limit under USP <729>, emulsion stability, peroxide and free-fatty-acid control, pH and osmolality, particulate and endotoxin, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, globule-size-distribution and emulsion-stability data, oxidation and peroxide-value data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile lipid-emulsion bottle and bag contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Fat Emulsion Injection Demands a Premium Manufacturer
Fat Emulsion Injection occupies a central, sometimes life-sustaining place in hospital nutrition across every market. It is the product a clinician relies on when a patient cannot be fed adequately by mouth or through the gut - after major abdominal surgery, in critical illness, in short-bowel and malabsorption states, in the preterm neonate - and needs calories and essential fatty acids delivered directly into the bloodstream. An intravenous lipid emulsion is a concentrated, energy-dense source of non-protein calories and a supply of the essential fatty acids the body cannot make for itself, and modern presentations range from the traditional soybean-oil emulsion to blends of medium-chain triglycerides, olive oil and fish oil that adjust the fatty-acid and omega-3 profile. What makes the dosage form distinctive is that it is not a simple solution but a fine oil-in-water emulsion - microscopic oil droplets suspended in water and held apart by a purified egg-yolk phospholipid emulsifier, made isotonic with glycerol - engineered to mimic the body's own natural chylomicrons. Because the emulsion is infused directly into a vein, often into a large central vein and often over many hours, every container must be sterile, stable and, above all, correctly sized at the droplet level, since the prescriber depends on a uniform, safe, reproducible emulsion.
That clinical reality places exceptional demands on the manufacturer. Fat Emulsion Injection is presented as a ready-to-use sterile emulsion - for example 20 g of oil per 100 mL, a 20% w/v emulsion, in a 100 mL, 250 mL or 500 mL glass bottle or non-PVC bag, infused slowly by the intravenous route - so the composition must be exact and the fill accurate so that each container delivers the labelled calories and fatty acids. The defining quality challenge is the droplet size distribution: the mean droplet size must be held to roughly a fifth of a micron, close to a natural chylomicron, and, critically, the tail of large-diameter globules must be tightly limited, because oversized fat globules can lodge in the pulmonary microcirculation. The pharmacopoeias make this explicit - USP General Chapter <729> sets a limit on the mean droplet size and, separately, a strict limit on PFAT5, the volume-weighted percentage of fat globules larger than 5 microns - and both must be met not only at release but across the whole shelf life. The emulsion must also resist creaming, coalescence and outright cracking, so the surface charge, the emulsifier level and the manufacturing energy are all controlled. Because the oils are rich in polyunsaturated fatty acids that are prone to oxidation, the peroxide value and free fatty acids must be held low, the product and headspace are protected under nitrogen, and light protection is applied. The manufacturer must then reconcile two competing needs: the emulsion must be fine and uniform, yet most presentations are terminally moist-heat sterilised, and the heat of the autoclave stresses the emulsion - so the formulation, the high-pressure homogenisation and the sterilisation cycle have to be co-designed so the emulsion survives sterilisation without breaking. Endotoxin must be very low, particulate controlled, pH and osmolality within range, and the label must carry infusion-rate limits, the risk of fat overload, triglyceride monitoring and egg, soya and peanut hypersensitivity cautions along with a clear do-not-freeze instruction. Choosing a Fat Emulsion Injection manufacturer that treats globule-size distribution, emulsion stability, oxidation control and the homogenisation-and-sterilisation design as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Fat Emulsion Injection Manufacturer Apart
A world-class manufacturer of Fat Emulsion Injection invests in three areas that weaker suppliers underfund: precise, validated control of the globule-size distribution - both the mean droplet size and the large-globule PFAT5 limit under USP <729> - which an intravenous emulsion absolutely demands; a robust, validated homogenisation, filling and terminal-sterilisation process built around a fine oil-in-water emulsion that must stay uniform, unbroken and un-oxidised from compounding through to the point of infusion; and tender-ready dossier support, including the globule-size, emulsion-stability and oxidation data, for a nutrition product procured through hospital-pharmacy and ministry-of-health channels. It starts with the raw materials - highly purified, low-peroxide injectable-grade oils, pharmacopoeial egg-yolk phospholipid, glycerol and, where used, an alpha-tocopherol antioxidant, each sourced from qualified, audited suppliers with full fatty-acid-composition, peroxide-value and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production. Because the entire value and safety of the product depend on building and preserving an extremely fine, uniform droplet population, the globule-size and emulsion-stability data are treated as central evidence rather than supporting annexes, and the oxidative quality of the oils is guarded from the first receipt of raw material.
Compounding and filling then have to build - and defend - the emulsion itself. The aqueous phase, carrying the phospholipid emulsifier and glycerol, and the oil phase are brought together and pre-emulsified, then driven through high-pressure homogenisation that shears the oil into sub-micron droplets, with the pH adjusted and the whole process carried out under nitrogen to exclude oxygen. The bulk emulsion is filled into glass bottles or non-PVC bags under ISO Class 5 conditions with a nitrogen headspace, and the validated terminal moist-heat sterilisation cycle - or, where the presentation requires, a fully aseptic route - is locked into the master batch record. Filled units are 100 % inspected for fill, seal and gross emulsion defects such as creaming, a visible oil layer or phase separation; in-process and release testing confirm the mean droplet size by dynamic light scattering, the large-globule PFAT5 fraction by light obscuration or single-particle optical sensing, the fatty-acid composition and oil content, the phospholipid and free-fatty-acid content, the peroxide value, pH, osmolality, deliverable volume, visible and sub-visible particulate matter, and that endotoxin is held well within limits so the emulsion is safe for intravenous infusion. Because the product is a heat-stressed emulsion whose safety hinges on droplet size, the globule-size distribution, emulsion stability, peroxide value and pH are confirmed together, before and after sterilisation, so the emulsion that leaves the plant is the same fine, uniform, un-oxidised emulsion the pharmacopoeia specifies - with no creaming, no coalescence, no cracking and no oversized-globule tail in the bottle or bag across shelf life.
Quality Systems Behind Every Fat Emulsion Injection
Every Farbe Firma Fat Emulsion Injection batch is released only after a full stack of quality checks: mean droplet size by dynamic light scattering and the large-globule PFAT5 limit by light obscuration under USP <729>, fatty-acid composition and oil assay by gas chromatography, phospholipid and free-fatty-acid content, peroxide value, solution pH and osmolality, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the bottle or bag format. Certificates of analysis are issued with full traceability back to each oil and phospholipid lot, the primary-packaging lot and the qualified person responsible for release. Because the emulsion is terminally sterilised, the globule-size distribution and the peroxide value are qualified both before and after the sterilisation cycle so the emulsion's stability to heat is demonstrated rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated high-pressure homogenisation and terminal-sterilisation equipment, validated filling lines with nitrogen purging and 100 % inspection, oxygen- and light-protected compounding and holding, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because an intravenous lipid emulsion is a delicate two-phase system given directly into the bloodstream and the globule-size distribution, emulsion stability and oxidative quality drive both efficacy and safety, we treat the mean droplet size, the PFAT5 large-globule limit, the peroxide value, the pH and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated conditions, with the globule-size distribution, peroxide value and emulsion appearance followed across the study, so the emulsion stays fine, uniform and within specification across the labelled shelf life - and the do-not-freeze storage instruction is supported by data, since freezing irreversibly cracks a lipid emulsion.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Fat Emulsion Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a growing parenteral-nutrition and large-volume-parenteral portfolio. For Fat Emulsion Injection specifically, we supply intravenous lipid emulsion in 10%, 20% and 30% w/v strengths and a range of oil compositions in glass-bottle and non-PVC-bag presentations under WHO-GMP conditions, with country-specific strengths, fill volumes, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the globule-size-distribution, emulsion-stability, oxidation-and-peroxide, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Fat Emulsion Injection can request the USP <729> globule-size and accelerated-stability summaries up front, which is often the deciding technical evidence for an intravenous lipid emulsion in hospital-formulary and ministry-of-health review, since it is precisely the large-globule limit and the emulsion's stability to heat and time that separate a safe lipid emulsion from an unsafe one.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability data, globule-size-distribution and emulsion-stability packages, sterilisation and container-closure reports, translated package inserts and artwork - including intravenous-infusion administration and infusion-rate instructions, store-below-25-degrees-C and do-not-freeze storage directions, and the fat-overload, hypertriglyceridaemia-monitoring and egg-, soya- and peanut-hypersensitivity cautions of the class - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Fat Emulsion Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the compounding, homogenisation and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through oil and phospholipid sourcing, the design of a fine, heat-stable oil-in-water emulsion, the control of the mean droplet size and the PFAT5 large-globule limit under USP <729>, high-pressure homogenisation and the co-design of the homogenisation and terminal-sterilisation cycle, nitrogen protection and peroxide-value control, emulsion physical stability and surface charge, fill accuracy, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For an intravenous lipid emulsion where the droplet-size distribution, emulsion stability and oxidative quality directly govern patient safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Fat Emulsion Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Fat Emulsion Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, dedicated two-phase compounding and high-pressure homogenisation lines with nitrogen protection, validated terminal sterilisation, 100 % inspection and continuous environmental monitoring.
Which strengths and presentations of Fat Emulsion Injection do you supply?
Our intravenous lipid emulsion is available in 10%, 20% and 30% w/v strengths and a range of oil compositions - from traditional soybean-oil emulsion to medium-chain-triglyceride, olive-oil and fish-oil-containing blends - in glass-bottle and non-PVC-bag presentations. Custom strengths, fill volumes, container formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Fat Emulsion Injection mainly used for?
Fat Emulsion Injection is used as a source of calories and essential fatty acids within parenteral nutrition for patients who cannot be fed adequately by the oral or enteral route, such as after major surgery, in critical illness or in malabsorption states. It is given by slow intravenous infusion, alone or as part of a total parenteral nutrition admixture; Farbe Firma verifies the mean droplet size, the PFAT5 large-globule limit, peroxide value, pH, osmolality, deliverable volume, particulate matter and endotoxin at release so each container delivers a fine, uniform, safe emulsion. Infusion-rate limits, the risk of fat overload, triglyceride monitoring and egg, soya and peanut hypersensitivity cautions are carried on the label.
Can Farbe Firma support country-specific registrations for Fat Emulsion Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability data, USP <729> globule-size-distribution and emulsion-stability packages, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Fat Emulsion Injection contract manufacturing?
MOQs vary by strength, oil composition, container format, sterilisation route, label complexity and dossier requirements. For our parenteral-nutrition and large-volume-parenteral presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments